Chunlin Wang
Papers
2
Total Citations
27
H-Index
1
About
Dr. Chunlin Wang is a leading colorectal surgeon whose research focuses on advancing robotic-assisted cancer surgery, particularly for colon and rectal cancers. His major contributions center on evaluating the efficacy and safety of emerging robotic platforms, most notably the Chinese-made Kangduo Surgical Robotic System, in comparison to the established Da Vinci Si system. In his landmark 2023 prospective cohort study, Dr. Wang demonstrated that the Kangduo system achieves comparable short-term oncologic outcomes to Da Vinci, providing critical evidence for expanding access to robotic surgery. With over 26 citations, this work has been instrumental in validating cost-effective alternatives in minimally invasive oncology. More recently, his 2025 post hoc analysis of a randomized controlled trial explored the surgical stress response in colorectal cancer patients, further solidifying the Kangduo system’s non-inferiority. By systematically comparing these platforms, Dr. Wang’s research not only broadens the technological landscape for colorectal cancer treatment but also addresses global disparities in surgical care. His work is essential reading for surgeons and researchers interested in the future of robotic surgery and its impact on patient recovery and outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2